Abstract
Background & Objective: Multiple classes of natural products, such as antiandrogens or steroids have been used as antioxidants and anti-inflammatory treatments in neurodegenerative diseases. This paper aims to review current knowledge on these substances and their possible relationship with free radicals as an alternative therapy and prevention of common neurological disorders. An exhaustive review of the neurochemical mechanisms of these substances in the central nervous system of humans and animal models is yet to be undertaken in the literature, particularly regarding their importance and increasing use.
Conclusion: Androgen receptor antagonists act in a different way that may underlie the benefits of natural products, with the expectation that in adults, neurological disorders would respond to natural antiandrogens. We hope that this work would provide valuable insight into the protective and therapeutic roles for natural antiandrogens and steroids in common neurological disorders.
Keywords: Androgens, antagonist, CNS, neurological disorders, neuroprotectors, steroids.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Natural Steroids and Androgen Antagonists used as Neuroprotection in Common Neurological Disorders
Volume: 16 Issue: 7
Author(s): David Calderon Guzman, Hugo Juarez Olguin*, Ernestina Hernandez Garcia, Monica Punzo Soto, Mayra Santillan Garcia and Gerardo Barragan Mejia
Affiliation:
- Laboratory of Pharmacology, National Institute of Pediatrics, Av. Iman No.1, 3rd piso, Colonia Cuicuilco. CP. 04530, Mexico City,Mexico
Keywords: Androgens, antagonist, CNS, neurological disorders, neuroprotectors, steroids.
Abstract: Background & Objective: Multiple classes of natural products, such as antiandrogens or steroids have been used as antioxidants and anti-inflammatory treatments in neurodegenerative diseases. This paper aims to review current knowledge on these substances and their possible relationship with free radicals as an alternative therapy and prevention of common neurological disorders. An exhaustive review of the neurochemical mechanisms of these substances in the central nervous system of humans and animal models is yet to be undertaken in the literature, particularly regarding their importance and increasing use.
Conclusion: Androgen receptor antagonists act in a different way that may underlie the benefits of natural products, with the expectation that in adults, neurological disorders would respond to natural antiandrogens. We hope that this work would provide valuable insight into the protective and therapeutic roles for natural antiandrogens and steroids in common neurological disorders.
Export Options
About this article
Cite this article as:
Guzman Calderon David , Olguin Juarez Hugo *, Garcia Hernandez Ernestina , Soto Punzo Monica , Garcia Santillan Mayra and Mejia Barragan Gerardo , Natural Steroids and Androgen Antagonists used as Neuroprotection in Common Neurological Disorders, CNS & Neurological Disorders - Drug Targets 2017; 16 (7) . https://dx.doi.org/10.2174/1871527316666170714121654
DOI https://dx.doi.org/10.2174/1871527316666170714121654 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issue: Endocrine Related Cancer: From Stem Cells to New Drug Targets)
Current Medicinal Chemistry Targeting the Ubiquitin-Proteasome Pathway in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry The Effect of PDE5 Inhibitors on the Male Reproductive Tract
Current Pharmaceutical Design Role of Angiopoietin-like 4 (ANGPTL4), a Member of Matricellular Proteins: from Homeostasis to Inflammation and Cancer Metastasis
Current Angiogenesis (Discontinued) Performance and Effect of Automatic Contouring in Automatic Adaptive Planning for Prostate Cancer Volumetric Modulated Radiotherapy
Recent Patents and Topics on Imaging (Discontinued) Cell-Selective Mitochondrial Targeting: Progress in Mitochondrial Medicine
Current Drug Delivery A Pilot Study for Investigation of Plasma Amino Acid Profile in Neurofibromatosis Type 1 Patients
Combinatorial Chemistry & High Throughput Screening The Chemical Structure and Bioactivity of Cycloartane-type Compounds
Current Organic Chemistry Radiologic Findings of IgG4-Related Disease
Current Immunology Reviews (Discontinued) Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel
Current Medicinal Chemistry Inhibition of Molecular Signaling in Huh-7 Cells by AM3: A Novel Chemotherapeutic Agent for Hepatocellular Carcinoma
Medicinal Chemistry The Role of Focal Adhesion Kinase in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
Current Cancer Drug Targets Aptamers Overview: Selection, Features and Applications
Current Topics in Medicinal Chemistry The GH/IGF-1 Axis in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Artificial Neural Networks in Cardiovascular Diseases and its Potential for Clinical Application in Molecular Imaging
Current Radiopharmaceuticals Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions
Current Drug Delivery The Use of the Bone Seeking Radiopharmaceutical 153-Samarium-EDTMP as an Adjuvant Treatment for Osteosarcoma: A Review
Current Medical Imaging Selectively Replicating Adenoviruses for Oncolytic Therapy
Current Cancer Drug Targets Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology